So Absorica still keeps the lights on three years later

anonymous

Guest
si get out there and sell using your managed care playbook.

It’s your fault if you have no share.


Seriously though what does sum make revenue on other than Absorica??
 
























well if I sat on my ass all year minus going to two meetings I would better with auto correct

When was the last time market access and those two stray cat women have been in the field?

All they do is get the Indian to buy data then they build reports

That’s it. When was your last good contract ??

You are worthless
 






well if I sat on my ass all year minus going to two meetings I would better with auto correct

When was the last time market access and those two stray cat women have been in the field?

All they do is get the Indian to buy data then they build reports

That’s it. When was your last good contract ??

You are worthless

Ok market access:

Name you 3 most impactful wins in 2018
 






























Since we have frozen positions it’s clear the end is near.


Taro, Tildra, PDT, Acne.

ALL of these are way underperforming in FY19.

Add on, if you’re a dermatologist, do you care about ANY of these products (do they provide a significant clinical difference, are they easier to treat and prescribe, and/or do I make more money)?

The answer is NO to all of those questions. SO, why then do they all exist?

The answer is “not for too much longer”

#thesunsetssoon
 






Taro, Tildra, PDT, Acne.

ALL of these are way underperforming in FY19.

Add on, if you’re a dermatologist, do you care about ANY of these products (do they provide a significant clinical difference, are they easier to treat and prescribe, and/or do I make more money)?

The answer is NO to all of those questions. SO, why then do they all exist?

The answer is “not for too much longer”

#thesunsetssoon

No frozen sales positions on the Tildra team. All are continuing to be filled.